Hatch-Waxman 101

This webinar has ended.

The Hatch-Waxman Act was enacted by Congress to encourage innovation in pharmaceutical research and development, and shorten the time to market for generic drugs. Fish’s award-winning life sciences practice has developed a four-part webinar series to examine and explain the Act in detail.

Chad Shear, an experienced life sciences trial lawyer, presented the first program in the series, Hatch-Waxman 101.

  • Introduce the Hatch-Waxman Act;
  • Explore the policy underpinning the Act;
  • Discuss the approval process and requirements; and
  • Examine how exclusivity works.

This complimentary webinar is perfect for those who have limited experience with the Hatch-Waxman Act. It will become the foundation for more advanced discussions in subsequent webinars in the series.